Teladoc Health Files 8-K on Financials
Ticker: TDOC · Form: 8-K · Filed: Feb 26, 2025 · CIK: 1477449
| Field | Detail |
|---|---|
| Company | Teladoc Health, Inc. (TDOC) |
| Form Type | 8-K |
| Filed Date | Feb 26, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
Related Tickers: TDOC
TL;DR
Teladoc Health dropped an 8-K on Feb 26th detailing their financials. Check it out.
AI Summary
Teladoc Health, Inc. filed an 8-K on February 26, 2025, reporting on its results of operations and financial condition. The filing also includes financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Purchase, NY.
Why It Matters
This filing provides investors with crucial updates on Teladoc Health's operational and financial performance, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine filing of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Teladoc Health, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Purchase, NY (location) — Principal executive offices
- February 26, 2025 (date) — Date of report
FAQ
What specific financial information is being reported in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on February 26, 2025.
What is the principal executive office address for Teladoc Health, Inc.?
The principal executive offices are located at 2 Manhattanville Road, Suite 203, Purchase, NY 10577.
Under which section of the Securities Exchange Act is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
What is the Commission File Number for Teladoc Health, Inc.?
The Commission File Number for Teladoc Health, Inc. is 001-37477.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 26, 2025 regarding Teladoc Health, Inc. (TDOC).